These data demonstrate that cfDNA is released by subcutaneously grown human tumor cells into the mouse bloodstream in sufficient quantity to calculate tumor cell gene copy number from blood plasma, and confirm proof-of-principle for using our ddPCR protocol to detect ALK and MYCN copy numbers from patient blood plasma samples. Here, ALK is linked to neoplasm.